| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/06/2002 | WO2002068381A2 Aryl-n-cyanoguanidines and methods related thereto |
| 09/06/2002 | WO2002068380A1 Synthetic excitatory amino acids |
| 09/06/2002 | WO2002068015A2 Modular infusion device and method |
| 09/06/2002 | WO2002067994A2 Compounds comprising an analgesic molecule linked to a vector that can vectorise said molecule through the hematoencephalic barrier and pharmaceutical compositions containing same |
| 09/06/2002 | WO2002067986A2 Symbiotic regenerative agent |
| 09/06/2002 | WO2002067976A1 Novel ischemia/reperfusion injury inhibitors |
| 09/06/2002 | WO2002067961A2 Therapeutic uses of herbal compositions |
| 09/06/2002 | WO2002067960A1 Herbal compositions useful as chemopreventive and therapeutic agents |
| 09/06/2002 | WO2002067959A1 Peptide derived from yeast having activities as anti-tsress, anti-fatigue and brain neurotrophic factor and relaxing premenstrual syndrome and menstrual pain, and prepairing process thereof |
| 09/06/2002 | WO2002067957A1 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 09/06/2002 | WO2002067955A2 A process for the manufacture of a herbal composition comprising a matrine |
| 09/06/2002 | WO2002067950A1 Vascular regeneration promoters |
| 09/06/2002 | WO2002067939A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/06/2002 | WO2002067933A1 New use of phencynonate hydrochloride |
| 09/06/2002 | WO2002067931A1 Treatment of tics, tremors and related disorders |
| 09/06/2002 | WO2002067927A1 Carbamate compounds for use in preventing or treating psychotic disorders |
| 09/06/2002 | WO2002067926A1 Carbamate compounds for use in preventing or treating movement disorders |
| 09/06/2002 | WO2002067925A1 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 09/06/2002 | WO2002067924A1 Carbamate compounds for use in preventing or treating bipolar disorder |
| 09/06/2002 | WO2002067923A1 Carbamate compounds for use in preventing or treating anxiety disorders |
| 09/06/2002 | WO2002067922A1 Carbamate compounds for use in the treatment of pain |
| 09/06/2002 | WO2002067921A1 Carbamate compounds for use in preventing or treating bipolar disorder |
| 09/06/2002 | WO2002067919A1 Il-8 receptor antagonists |
| 09/06/2002 | WO2002067917A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | WO2002067916A2 Pharmaceutical salts |
| 09/06/2002 | WO2002067906A1 Coating and binding agent for pharmaceutical formulations with improved storage stability |
| 09/06/2002 | WO2002067903A2 Compositions and methods of manufacture for oral dissolvable dosage forms |
| 09/06/2002 | WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 09/06/2002 | WO2002067851A2 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | WO2002067764A2 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 09/06/2002 | WO2002067760A2 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 09/06/2002 | WO2002067651A2 Pharmaceutical salts |
| 09/06/2002 | WO2002051832A3 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
| 09/06/2002 | WO2002046183A3 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 09/06/2002 | WO2002044170A3 Benzothiophene derivative compounds, process of preparation and use thereof |
| 09/06/2002 | WO2002043654A3 Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions |
| 09/06/2002 | WO2002043648A8 Compounds active at the glucocorticoid receptor ii |
| 09/06/2002 | WO2002041882A3 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 09/06/2002 | WO2002040517A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002040037A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002036792A3 Dna expression vectors |
| 09/06/2002 | WO2002034889A3 Therapeutic uses for mesenchymal stromal cells |
| 09/06/2002 | WO2002030405A3 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 09/06/2002 | WO2002016574A3 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 09/06/2002 | WO2002008449A3 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/06/2002 | WO2002007726A3 Treatment of movement disorders |
| 09/06/2002 | WO2002005859A3 Radiotherapy |
| 09/06/2002 | WO2002002629A3 Grf2-binding proteins and applications thereof |
| 09/06/2002 | WO2001094612A3 Method for identifying medically valuable active substances |
| 09/06/2002 | WO2001092479A3 Method to determine the differentiation potential of a target cell |
| 09/06/2002 | WO2001058915A8 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 09/06/2002 | WO2001049687A9 Cyclohexene nucleic acids |
| 09/06/2002 | WO2001041751A3 Phytoestrogens for treating als |
| 09/06/2002 | WO2001032614A9 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 09/06/2002 | WO2001031021A9 Multiple sclerosis-related superantigen |
| 09/06/2002 | WO2001024792A9 Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog |
| 09/06/2002 | WO2001018546A9 Screening for inhibitors of 'paired helical filaments' |
| 09/06/2002 | WO2001015553A9 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 09/06/2002 | WO2001012236A9 Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 09/06/2002 | WO2001012170A3 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 09/06/2002 | WO2000067761A9 Compositions and methods for identifying antigens which elicit an immune response |
| 09/06/2002 | CA2756609A1 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 09/06/2002 | CA2725635A1 Pharmaceutical salts of 6-dimethylaminomethyl-1-phenylcyclohexane compounds |
| 09/06/2002 | CA2475454A1 Aryl-n-cyanoguanidines and methods related thereto |
| 09/06/2002 | CA2439468A1 New crystal forms of lamotrigine and processes for their preparations |
| 09/06/2002 | CA2439376A1 Compositions and methods of manufacture for oral dissolvable dosage forms |
| 09/06/2002 | CA2439292A1 Carbamate compounds for use in preventing or treating bipolar disorder |
| 09/06/2002 | CA2439286A1 Carbamate compounds for use in preventing or treating anxiety disorders |
| 09/06/2002 | CA2439265A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/06/2002 | CA2438930A1 Treatment of tics, tremors and related disorders |
| 09/06/2002 | CA2438895A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 09/06/2002 | CA2438890A1 Novel substituted imidazotriazinones |
| 09/06/2002 | CA2438828A1 Aryl carbamate derivatives, preparation and use thereof |
| 09/06/2002 | CA2438824A1 Compounds comprising an analgesic molecule linked to a vector that can vectorise said molecule through the hematoencephalic barrier and pharmaceutical compositions containing same |
| 09/06/2002 | CA2438784A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | CA2438238A1 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | CA2437898A1 Interferon-alpha induced gene |
| 09/06/2002 | CA2437530A1 Symbiotic regenerative agent |
| 09/06/2002 | CA2437516A1 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2434666A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 09/06/2002 | CA2433425A1 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | CA2426538A1 Tricyclic compounds and their uses |
| 09/05/2002 | US20020124272 Diploid animal cell for use in the treatment of drug addiction, epilepsey, withdrawal syndrome and muscle spasm |
| 09/05/2002 | US20020123652 2-aminotetralines and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 09/05/2002 | US20020123632 Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker |
| 09/05/2002 | US20020123614 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 09/05/2002 | US20020123520 3',5'-cyclic nucleotide phosphodiesterases (PDEs); disease related to eosinophils, such as asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
| 09/05/2002 | US20020123516 Synergistic mixture of idebenone and nimodipine |
| 09/05/2002 | US20020123510 Administering an NR2B subtype selective N-methyl-D-aspartate (NMDA) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke |
| 09/05/2002 | US20020123507 Bicyclic derivatives |
| 09/05/2002 | US20020123501 Useful for premature aging, rheumatoid arthritis, Alzheimer's disease, uremia, neurotoxicity, atherosclerosis and spoilage of proteins in food |
| 09/05/2002 | US20020123495 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death |
| 09/05/2002 | US20020123494 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death |
| 09/05/2002 | US20020123493 For therapy and prophylaxis of neuronal damage |
| 09/05/2002 | US20020123492 Beta-amino acid derivatives |
| 09/05/2002 | US20020123490 Combination treatment for anxiety, depression, obsessive compulsive disorder and psychosis |
| 09/05/2002 | US20020123488 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine |
| 09/05/2002 | US20020123486 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 09/05/2002 | US20020123471 Useful as a gene transfer vehicle for gene therapy, i.e. of the central nervous system |